Medicines Identified as Low Priority for Funding in NHS Wales – Paper 2
- Source:
- All Wales Medicines Strategy Group - AWMSG
- Publisher:
- All Wales Medicines Strategy Group (AWMSG)
- Publication date:
- 01 December 2018
Abstract
Four medicines/medicine groups have been identified for the purposes of this document: omega-3 fatty acid compounds, oxycodone and naloxone combination product, paracetamol and tramadol combination product and perindopril arginine.